27 / 28
Page 83
International Journal of Emergency Mental Health and Human Resilience | ISSN: 1522-4821 | Volume 20
November 26-27, 2018 | Los Angeles, USA
Psychiatry, Mental Health Nursing and Healthcare
World Summit on
Applied Psychology, Psychiatry and Mental Health
International Conference on
&
Ketamine infusion therapy: An innovative approach to rapid relief from depression and suicidality
Steven L Mandel
Ketamine Clinics of Los Angeles, USA
D
epression is the leading cause of disability worldwide. Suicide often follows depression when it goes unchecked. Depression
is the 10th leading cause of death in the United States. “Recent data suggest that ketamine, given intravenously, might be the
most important breakthrough in antidepressant treatment in decades,” according to Dr Thomas Insel, the former Director of the
National Institute of Mental Health. For the past two decades researchers at Yale University, the National Institute of Health, Harvard
University, John Hopkins University, Mount Sinai Medical School, Stanford University, among others, have studied ketamine given
intravenously for the treatment of major depressive disorder. Their findings have been consistently groundbreaking. In study after
study, 70% of subjects suffering from treatment-resistant depression have been relieved of their depression. The typical protocol is to
administer a subanesthetic dose of ketamine (usually 0.5mg/kg body weight) over a 40 minute infusion. Most clinics offer 6 infusions
administered over 2 weeks for the initial series of treatments. Patients find relief from depressive symptoms within a few hours to
a few days, as opposed to the 4-6 weeks that most conventional antidepressant medications take. Patients seek Ketamine Infusion
Therapy for treatment-resistant depression, suicidality, PTSD, anxiety, OCD, bipolar disorder, PPD and addiction. Ketamine Infusion
Therapy should be offered to patients suffering from these afflictions. It is an excellent option, particularly for those who have not
benefited from other treatments. Educating medical professionals on the benefits, safety and efficacy of Ketamine Infusion Therapy
and making it more available to patients will save lives.
info@ketamineclinics.comInt J Emerg Ment Health, Volume 20
DOI: 10.4172/1522-4821-C5-024